Sinopharm Group
 |
|
| Type | State-owned enterprise (Red chip) |
|---|---|
| Industry | Pharmaceutical |
| Founded | 2003 |
| Headquarters | Shanghai, People's Republic of China |
| Area served | People's Republic of China |
| Key people | Chairman: Mr. She Lulin |
| Services | Foreign Trade |
| Parent | China National Pharmaceutical Group Corporation |
| Website | Sinopharm Group Company Limited |
Sinopharm Group Company Limited (SEHK: 01099) is the largest pharmaceutical company in China, jointly owned by China National Pharmaceutical Group Corporation and Shanghai Fosun Pharmaceutical. Its revenue in 2007 reached 35 billion RMB.[1][2]
Sinopharm Group researches and develops, manufactures, distributes, and markets medicine and other healthcare products. Sinopharm Group manages factories, research laboratories, traditional Chinese medicine plantations, and marketing and distribution networks that extend throughout China. It also has 10 subsidiaries and a number of major joint ventures. The company also runs about a dozen retail pharmacy chains. Sinopharm Group, which has operations in Africa, France, Germany, Hong Kong, the US, and Vietnam, was formed in 1998.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share.
[edit] See also
[edit] References
[edit] External links
|
|||||
- Companies listed on the Hong Kong Stock Exchange
- Hang Seng China Enterprise Index Constitute Stock
- Companies based in Shanghai
- Government-owned companies of the People's Republic of China
- Pharmaceutical companies of China
- Fosun International
- Companies established in 2003
- Retail companies of China
- Warrants issued in Hong Kong Stock Exchange
